Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2016 Jan 11.
Published in final edited form as: Clin Perinatol. 2015 Jun;42(2):243–viii. doi: 10.1016/j.clp.2015.02.002

EVALUATION AND DIAGNOSIS OF THE DYSMORPHIC INFANT

Kelly L Jones 1, Margaret P Adam 1,*
PMCID: PMC4707958  NIHMSID: NIHMS734081  PMID: 26042903

SYNOPSIS

Neonatologists often have the unique opportunity to be the first to identify abnormalities in the neonate. In this review, multiple anomalies and physical features are discussed along with the potential associated genetic syndromes. The anomalies and physical features that are discussed include birth parameters, aplasia cutis congenita, holoprosencephaly, asymmetric crying facies, preauricular ear tags and pits, cleft lip with or without cleft palate, esophageal atresia/tracheoesophageal fistula, congenital heart defects, ventral wall defects, and polydactyly.

Keywords: Aplasia cutis congenita, holoprosencephaly, asymmetric crying facies, preauricular tags, cleft lip with or without cleft palate, congenital heart defects, ventral wall defects, polydactyly

INTRODUCTION

Congenital anomalies are present in at least 10% of all neonatal intensive care unit admissions, of whom many have an underlying genetic condition.1 Neonatologists are often the first physicians to evaluate these infants and consequently need to be familiar with various physical differences in order to pursue further screening for occult malformations, perform diagnostic testing and appropriately counsel families. The purpose of this article is review the dysmorphology examination with particular attention to anomalies that are readily apparent in the neonatal period.

An anomaly is a structural defect that deviates from the normal standard and can be categorized as major or minor. A major anomaly has surgical, medical or cosmetic importance and may be a marker for other occult malformations. A minor anomaly has no significant surgical or cosmetic importance; however, many genetic syndromes are recognized based on the pattern of minor anomalies present. Anomalies arise from one of three mechanisms, each of which has different diagnostic and inheritance implications. The first mechanism is termed a malformation, which is a structural defect arising from an intrinsically abnormal developmental process. Malformations include anomalies like congenital heart defects and cleft lip and palate. These types of anomalies are more likely to be associated with a genetic condition or predisposition. A deformation is an abnormality arising from prenatal mechanical forces on otherwise normally formed fetal structures. Deformations can include clubfeet, overlapping toes and unusual head shape (although these disorders may also be malformations). Deformations are rarely genetic and recurrence risks are typically low. Lastly, disruptions are structural defects resulting from the destruction or interruption of intrinsically normal tissue. Examples of disruptive anomalies include limb reduction defects from amniotic band sequence and certain types of intestinal atresias due to vascular insufficiency.2 Anomalies due to this mechanism are much less likely to be due to a genetic condition or to recur in a future pregnancy.

BIRTH PARAMETERS

Both increased and decreased birth parameters are associated with multiple genetic and non-genetic etiologies. Fetal macrosomia may be defined as a birth weight greater than 4000g or more than two standard deviations above the mean of a reference population, while fetal-growth restriction is defined as a birth weight less than two standard deviations below the mean for gestational age in a reference population. The differential diagnoses for both fetal macrosomia and fetal growth restriction are broad and include chromosomal abnormalities and teratogenic exposures. Chromosomal abnormalities have varying phenotypes depending on the size of the chromosomal segment involved and the individual genes in that segment. Consequently, it is beneficial to evaluate for congenital anomalies in those who have macrosomia or growth restriction. In both instances, a chromosomal microarray should be considered. If the physical examination indicates features of a well-characterized genetic syndrome, such as a trisomy or Beckwith-Wiedemann syndrome, then testing can be tailored to that particular syndrome (Tables 1 and 2). 38

Table 1.

Overgrowth in the neonatal period and associated conditions

Differential diagnosis Associated features Potential evaluations Potential genetic studies
Beckwith-Wiedemann syndrome Macroglossia
Abdominal wall defects
Hemihyperplasia
Neonatal hypoglycemia
Visceromegaly
Posterior helical ear pits
Anterior linear ear lobe creases
Blood glucose level monitoring
Abdominal ultrasound
Alpha-fetoprotein level
Methylation analysis of 11p15
Chromosomal abnormalities Congenital heart defects
Ophthalmologic abnormalities
Genitourinary abnormalities
Echocardiogram
Ophthalmologic evaluation
Renal ultrasound
Chromosomal microarray
Infant of a diabetic mother Holoprosencephaly
Spina bifida
Congenital heart defects
Neonatal small left colon
Vertebral defects
Tibial hemimelia with preaxial polydactyly
Caudal regression syndrome
Cranial ultrasound or head MRI
Echocardiogram
Renal ultrasound
Sacral ultrasound
AP and lateral radiographs of the entire spine
None

MRI = magnetic resonance imaging; AP = anterior-posterior

Table 2.

Fetal growth restriction and associated genetic conditions

Differential diagnosis Associated features Potential evaluations Potential genetic studies
Chromosomal abnormalities (See Table 1) (See Table 1) (See Table 1)
Trisomy 13 Holoprosencephaly
Microphthalmia/ colobomas
Congenital heart defects
Cutis aplasia
Head ultrasound
Ophthalmologic evaluation
Echocardiogram
Renal ultrasound
Karyotype
Trisomy 18 Prominent occiput
Micrognathia
Congenital heart defects
Horseshoe kidney
Overlapping fingers
Echocardiogram
Renal ultrasound
Karyotype

While abnormal birth parameters in the presence of congenital anomalies frequently indicate a genetic syndrome, this is not always the case. For example, infants of diabetic mothers are commonly macrosomic (although growth restriction can also occur) and may display congenital malformations at a frequency of two to four times the general population rate. Consequently, it may be difficult to distinguish between diabetic embryopathy and a genetic syndrome.4 In the absence of confirmed maternal diabetes and one of the more specific anomalies seen in diabetic embryopathy, such as caudal regression syndrome or tibial hemimelia with preaxial polydactyly (Figure 1), this diagnosis should be considered a diagnosis of exclusion and the clinician should consider further genetic testing, such as a chromosomal microarray to evaluate for a chromosome abnormality.2,3

Figure 1.

Figure 1

Tibial hemimelia with proximally placed preaxial polydactyly of the right foot in an infant born to a women with poorly-controlled insulin dependent diabetes. Note the short and bowed lower extremity with a dimple around the knee (from Adam MP et al., Birth Defects Res A Clin Mol Teratol 85:14, 2009).

Similarly, fetal growth restriction can be due to non-genetic causes, such as placental insufficiency, maternal hypertension, multiple gestation (i.e. twinning), and maternal pre-eclampsia. Most of these conditions result in asymmetric growth restriction as a result of inadequate nutrient transfer to the fetus.9 Placental insufficiency has also been associated with an increased risk of hypospadias in males;10 therefore, not all birth defects associated with growth restriction will be genetic. However, as with diabetic embryopathy, this type of teratogenic mechanism should remain a diagnosis of exclusion and chromosomal microarray in such infants should be considered.

APLASIA CUTIS CONGENITA

Aplasia cutis congenita (ACC) is congenital absence of the skin. While ACC can occur on any part of the body, it most commonly affects the scalp (70-80% of cases). The majority of cases are sporadic solitary scalp lesions but 15-30% of scalp ACC are associated with defects in the underlying bone and dura.11 ACC may be associated with etiological factors including birth trauma, intrauterine infections with varicella zoster or herpes viruses, fetus papyraceous and teratogens, like cocaine and methimazole.11,12 ACC has also been associated with multiple genetic conditions including trisomy 13 and Adams-Oliver syndrome (AOS), a condition characterized by ACC and terminal limb defects. AOS can be inherited in either an autosomal dominant or an autosomal recessive fashion (Table 3).7,11,13 Complications of ACC include infection, meningitis, bleeding, and superior sagittal sinus thrombosis. Mortality for those with ACC is 20-50% and is dependent on the size of the lesion and any associated defects. Solitary scalp ACC that is small in size and lateral to the midline usually does not require further diagnostic evaluation per se; however, if a scalp or back defect is midline or membranous in quality, a brain MRI or spine ultrasound or MRI to evaluate for an underlying neural tube defect should be considered. Treatment for ACC is usually conservative.11 After healing, areas of scalp affected by ACC will not grow any hair (Figure 2).

Table 3.

Aplasia cutis congenita and associated genetic conditions

Differential diagnosis Associated features Potential evaluations Potential genetic studies
Adams-Oliver Limb defects
Cutis marmorata telangiectasia congenita
CNS abnormalities
Cardiovascular abnormalities
Brain imaging
Limb radiographs
Echocardiogram
Sequencing of ARHGAP31, DOCK6, RBPJ, EOGT
Scalp or midline back ACC (without multiple anomalies) May have underlying bony or neural tube defects Infectious work up
Skull radiograph
Head MRI
Spinal ultrasound or MRI
None
Trisomy 13 (See Table 2) (See Table 2) (See Table 2)

CNS = central nervous system; MRI = magnetic resonance imaging

Figure 2.

Figure 2

Arrows point to two small areas of cutis aplasia congenita on the scalp that have healed, demonstrating that no hair grows in the healed areas.

HOLOPROSENCEPHALY

Holoprosencephaly (HPE) is a structural brain abnormality resulting from the incomplete cleavage of the forebrain into the right and left hemispheres during the third to fourth week of gestation. HPE consists of a continuum of brain malformations with alobar HPE (a single ventricle and no separation of the cerebral hemispheres (Figure 3A)) at one end of the spectrum to very mild midbrain fusion (Figure 3B) at the other end of the spectrum.

Figure 3.

Figure 3

(A) Brain MRI image of an infant with alobar holoprosencephaly, the most severe form of holoprosencephaly, demonstrating a single large ventricle. (B) Brain MRI image of an infant with a milder form of holoprosencephaly in which there is subtle fusion of the thalami (arrows).

HPE may be associated with a range of craniofacial abnormalities including cyclopia, microcephaly, hypotelorism, depressed nasal bridge, single maxillary incisor and midline cleft lip with or without cleft palate (Figure 4). Some affected individuals also have pituitary dysfunction and feeding difficulties. The HPE phenotype is variable among simplex cases and among members of the same family with an inherited form of HPE; consequently, subtle facial features may be overlooked in mildly affected family members. In any infant for whom HPE is being considered, first degree relatives should be questioned and examined to identify those with microcephaly, hypotelorism, or a single central incisor. Due to variable expressivity of the phenotype, affected first degree family members may be very mildly affected. Since some cases of HPE are inherited in an autosomal dominant fashion, identifying other affected family members has implications for genetic testing and recurrence risks.14,15

Figure 4.

Figure 4

This infant with holoprosencephaly has microcephaly, hypotelorism, a hypoplastic nose, and a midline cleft of the lip and palate. The white arrow points to hypoplastic nares and the black arrow points to the large midline cleft lip and palate.

The etiologies for both syndromic and non-syndromic HPE are heterogeneous and include maternal diabetes mellitus, single gene disorders (often inherited in an autosomal dominant manner), and chromosomal abnormalities (Table 4).3,7,16 Chromosomal abnormalities are present in up to 50% of patients with HPE and include trisomy 13, trisomy 18, and a variety of other copy number variants. Determining which laboratory testing to perform depends on family history and the presence of other abnormalities. Testing may include routine chromosome analysis (if trisomy 13 or 18 is suspected) or chromosomal microarray analysis. Further single gene testing may be considered in those with a family history suggestive of an inherited form of HPE, with mutations in SHH accounting for up to 30-40% of familial cases.16 Treatment is multidisciplinary and may include pituitary hormone replacement, antiepileptic medications and surgical repair of midline cleft lip with or without cleft palate in those who are more mildly affected.15

Table 4.

Holoprosencephaly and associated conditions

Differential diagnosis Associated features Potential evaluations Potential genetic studies
Chromosomal abnormalities (See Table 1) (See Table 1) (See Table 1)
Infant of diabetic mother (See Table 1) (See Table 1) (See Table 1)
Single gene disorder Microcephaly
Hypotelorism
Nasal hypoplasia
Midline cleft lip with or without palate
Single central incisor
Head MRI imaging
Dental evaluation in those where teeth have erupted
Sequencing of SHH, ZIC2, SIX3, TGIF1, GLI2, PTCH
Trisomy 13 (See Table 2) (See Table 2) (See Table 2)
Trisomy 18 (See Table 2) (See Table 2) (See Table 2)

ASYMMETRIC CRYING FACIES

Aysmmetric crying facies (ACF) is a minor anomaly, which presents with drooping of the corner of the mouth on the unaffected side when crying or grimacing. Asymmetric crying facies is typically due to congenital absence of the depressor anguli oris muscle (DAOM). Individuals with ACF have preservation of the nasolabial fold depth bilaterally and retain the ability to wrinkle their forehead and to close both eyes equally well, all of which distinguishes this anomaly from the less common facial nerve palsy.2 ACF has been associated with other congenital anomalies in 20-70% of cases. Most anomalies are found in the head/neck and cardiovascular systems but they can also involve the skeletal, genitourinary, and gastrointestinal systems. In particular, ACF has been associated with the 22q11 deletion syndrome (also known as velocardiofacial or DiGeorge syndrome); consequently, individuals with ACF should be evaluated for signs of velocardiofacial syndrome, including dysmorphic facial features, congenital heart defects, and long fingers/toes. Long term follow up should focus on evaluation of growth and development and standard treatment of associated anomalies, if present (Table 5).17,18

Table 5.

Asymmetric crying facies and associated conditions

Syndromes/conditions to consider Associated features Potential evaluations Potential genetic studies
Isolated congenital absence or hypoplasia of depressor anguli oris muscle Congenital heart defects Echocardiogram None
22q11 deletion Laterally built up nose
Aplasia/hypoplasia of thymus
Hypocalcemia
Congenital heart defects
Long fingers and toes
Renal anomalies
Ionized calcium and intact parathyroid hormone levels
Thyroid function tests
Immunology evaluation
Echocardiogram
Hearing screen
Renal ultrasound
Ophthalmologic evaluation
Chromosomal microarray or FISH for 22q11 deletion

PREAURICULAR EAR TAGS AND PITS

Preauricular ear tags and pits are frequent findings on routine neonatal physical examinations. Preauricular tags are small, skin-colored nodules that can be found anywhere along a line drawn from the tragus to the angle of the mouth (Figure 5). Preauricular pits are small openings at the anterior margin of the crus of the helix. Both of these anomalies can be found in isolation or as part of a genetic syndrome. All patients with a preauricular tag or pit should have a hearing assessment because abnormalities of the external ear may be associated with middle or inner ear abnormalities and hearing loss. Furthermore, these patients should be examined for any other malformations, which may indicate an underlying genetic syndrome like craniofacial microsomia or branchio-otorenal (BOR) syndrome (Tables 6 and 7).2,19,20 The association of preauricular ear tags and pits with urinary tract anomalies has also been studied previously.20,21 Wang et al. (2001) suggested renal ultrasound only when ear tags or pits are associated with other malformations or dysmorphic features, a family history of hearing loss or ear anomalies, or if there is a history of maternal gestational diabetes or teratogen exposure.21 In the absence of these findings, the preauricular tags and pits are presumed to be isolated and no further evaluation is needed.

Figure 5.

Figure 5

Arrow pointing to small isolated right preauricular skin tag (from Adam and Hudgins, NeoReviews 4:e99-e104, 2003).

Table 6.

Conditions associated with preauricular ear tags

Differential diagnosis Associated features Potential evaluations Potential genetic studies
Craniofacial Microsomia External ear anomalies
Hearing loss
Cleft palate
Maxillary and/or mandibular hypoplasia
Renal anomalies
Audiology evaluation
Renal ultrasound
Chromosomal microarray
Isolated May have a positive family history Audiology evaluation None

Table 7.

Conditions associated with preauricular ear pits

Differential diagnosis Associated features Potential evaluations Potential genetic studies
Branchio-otorenal syndrome External ear anomalies
Brachial cleft fistulae
Renal anomalies
Audiology evaluation
Renal ultrasound
Sequencing of EYA1, SIX5, SIX1
Craniofacial Microsomia (See Table 6) (See Table 6) (See Table 6)

OROFACIAL CLEFTING

Orofacial clefts, including cleft lip with or without cleft palate (CLP) and cleft palate only (CP), are the most common craniofacial birth defects in humans with an incidence of 1 in 700 to 1 in 1,000 live births. Subclinical phenotypes may occur and include microform clefts, bifid uvula, submucous CP and velopharyngeal insufficiency. Most orofacial clefts occur in isolation, presumably due to the combined effect of genetic and environmental factors. However, approximately 30% of CLP and 50% of CP are associated with other malformations, most commonly cerebral, dental, and cardiovascular anomalies.22 The risk of associated anomalies is even higher in the presence of bilateral clefts. Hearing loss also commonly occurs. The constellation of anomalies may indicate an underlying genetic syndrome, which may require further evaluation (Tables 8 and 9).7,15,18,2327

Table 8.

Cleft palate with or without cleft lip associated genetic conditions

Differential diagnosis Associated features Potential evaluations Potential genetic studies
Holoprosencephaly (if cleft is midline) (See Table 4) (See Table 4) (See Table 4)
Isolated cleft lip/palate None Audiology evaluation
Feeding assessment
None
Trisomy 13 (See Table 2) (See Table 2) (See Table 2)
Van der Woude Lower lip pits Feeding assessment Sequencing of IRF6

Table 9.

Cleft palate WITHOUT cleft lip and associated conditions

Differential diagnosis Associated features Potential evaluations Potential genetic studies
22q11 deletion (See Table 5) (See Table 5) (See Table 5)
CHARGE Coloboma
Ear anomalies
Cardiac defects
Choanal atresia
Genitourinary abnormalities
Omphalocele
Audiology evaluation
ENT evaluation
Echocardiogram
Ophthalmologic evaluation
Renal ultrasound
Sequencing of CHD7
Isolated cleft palate None None None
Smith-Lemli-Optiz Microcephaly
Characteristic facial features
Cataracts
Hypospadias
Postaxial polydactyly
2-3 toe syndactyly
7-dehydrocholesterol and total cholesterol levels
Echocardiogram
Ophthalmologic evaluation
Sequencing DHCR7
Stickler Myopia
Cataract
Retinal detachment
Hearing loss
Spondyloephiphyseal dysplasia
Audiology evaluation
Ophthalmologic evaluation
Sequencing of COL2A1, COL9A1, COL9A2, COL11A1, and COL11A2
Treacher-Collins Lower eyelid abnormalities
Microtia and other external ear abnormalities
Zygomatic bone hypoplasia
Airway and feeding evaluations
Audiology evaluation
Sequencing of TCOF1, POLR1C, and POLR1D

ENT = ear, nose, throat

The management of a neonate with an orofacial cleft is multidisciplinary with priority given to respiratory and nutritional support. The cleft itself is treated with orthodontic and surgical interventions. Other services, such as speech therapy, and interventions may be required depending on the clinical presentation (see chapter 8 for a more detailed discussion).27

CARDIAC DEFECTS

Congenital heart disease (CHD) is the most common major congenital anomaly seen by neonatologists and a major cause of neonatal morbidity and mortality. There are multiple etiologies for CHD. Isolated CHD is thought to be the result of multifactorial inheritance with both genetic and environmental factors contributing to the malformation. Other CHDs are due to teratogenic effects of infections (e.g. rubella and influenza), maternal factors (e.g. diabetes mellitus and phenylketonuria), and prenatal exposures (e.g. anticonvulsants and alcohol).3,28,29

Genetic etiologies are significant causes of CHD and include trisomies, 45,X (Turner syndrome), chromosomal deletions and/or duplications, and single gene disorders. While no single cardiac defect is pathognomonic for a particular genetic syndrome, there are certain cardiac defects that are more prevalent in specific syndromes. For example, the 22q11 deletion is present in about 50-90% of neonates with an interrupted aortic arch but it is also present in neonates with tetralogy of Fallot, truncus arterious and ventricular septal defects. Furthermore, many of the patients with CHD and an underlying genetic syndrome have other associated features that will help guide further evaluation and testing (Table 10).18,2933

Table 10.

Cardiac defects and associated genetic syndromes

Cardiac Defect Genetic syndrome Associated features Potential evaluations Potential genetic studies
Atrial septal defect Holt-Oram Upper limb malformation
Cardiac conduction disease
Upper limb radiographs
Echocardiogram
Sequencing of TBX5
Atrioventricular canal Down (trisomy 21) Up-slanting palpebral fissures
5th finger clinodactyly
Single transverse palmar creases
Increased gap between 1st and 2nd toes
Audiology evaluation
Complete blood count
Ophthalmologic evaluation
Thyroid function tests
Karyotype
Coarctation of the aorta Kabuki Long palpebral fissures
Large ears
Spinal column abnormalities
Postnatal growth deficiency
Ophthalmologic evaluation
Renal ultrasound
Spine radiographs
Sequencing of KMT2D and KDM6A
Turner Webbed posterior neck
Broad chest with wide-spaced nipples
Lymphedema of hands and feet
Audiology evaluation
Renal ultrasound
Thyroid function tests
Karyotype
Hypoplastic left heart syndrome Turner (see above) (see above) (see above)
Interrupted aortic arch 22q11 deletion (See Table 5) (See Table 5) (See Table 5)
Peripheral pulmonary artery stenosis Alagille Bile duct paucity
Butterfly vertebrae
Posterior embryotoxon
Abdominal ultrasound
Chest radiographs
Liver function tests
Ophthalmologic evaluation
Sequencing of JAG1
Pulmonary valve stenosis Noonan Tall forehead
Hypertelorism
Down-slanting palpebral fissures
Low-set, posteriorly rotated ears
Excess nuchal skin
Low posterior hairline
Ophthalmologic evaluation
Renal ultrasound
Molecular testing: at least 12 genes, including PTPN11 (multigene panel testing available)
Supravavular aortic stenosis Williams Hypercalcemia
Hypotonia
Peripheral pulmonic stenosis
Failure to thrive
Renal artery stenosis
Bladder and kidney ultrasound
Calcium level
Ophthalmologic evaluation
Microarray or deletion testing for 7q11.23
Tetralogy of Fallot 22q11 deletion (See Table 5) (See Table 5) (See Table 5)
Ventricular septal defect Down (trisomy 21) (see above) (see above) (see above)
22q11 deletion (See Table 5) (See Table 5) (See Table 5)

ESOPHAGEAL ATRESIA/TRACHEOESOPHAGEAL FISTULA

Esophageal atresia (EA) is a developmental defect of the foregut characterized by the discontinuity of the esophagus. It is frequently associated with a tracheoesophageal fistula (TEF) and in approximately half of affected individuals, the EA/TEF anomalies are associated with other congenital anomalies.34,35 There is a broad spectrum of anomalies associated with EA/TEF, including microcephaly, single umbilical artery and duodenal atresia. Vertebral, anorectal, cardiac, and genitourinary anomalies are some of the most frequent and are a part of the VACTERL association. VACTERL association is considered when at least three features of the association are present. The genetic etiology of VACTERL has not been elucidated and it is thought to be multifactorial, although some cases may be due to teratogenic exposure, such as maternal diabetes. Therefore, VACTERL association is not considered a genetic syndrome and should be considered a diagnosis of exclusion. In individuals for whom a diagnosis of VACTERL association is being entertained, chromosomal microarray and chromosomal breakage studies for Fanconi anemia should be considered. Other genetic syndromes associated with EA/TEF include CHARGE syndrome, Down syndrome, trisomy 18 and other chromosomal abnormalities (Table 11).3,79,25,3437

Table 11.

Tracheoesophageal fistula and associated conditions

Differential diagnosis Associated features Potential evaluations Potential genetic studies
Infant of a diabetic mother (See Table 1) (See Table 1) (See Table 1)
Down (trisomy 21) (See Table 10) (See Table 10) (See Table 10)
CHARGE (See Table 9) (See Table 9) (See Table 9)
Chromosomal abnormalities (See Table 1) (See Table 1) (See Table 1)
Fanconi anemia Microcephaly
Short stature
Pigmentary abnormalities
Thumb abnormalities (absent/hypoplastic, bifid, duplicated, etc)
Other upper extremity abnormalities
Lower extremity abnormalities
Genitourinary abnormalities
Pancytopenia
Hematologic studies including complete blood count and bone marrow aspirate
Renal ultrasound
Chromosomal breakage studies
Molecular testing; at least 16 genes, including FANCA and BRCA2
Trisomy 18 (See Table 2) (See Table 2) (See Table 2)
VACTERL association Vertebral defects
Anal atresia/ imperforate anus
Cardiac defects
Tracheoesophageal fistula
Limb anomalies
Renal anomalies
Abdominal x-rays
AP and lateral radiographs of the entire spine
Echocardiogram
Radiographs of affected limbs
Renal ultrasound
None

VENTRAL WALL DEFECTS

Omphalocele and gastroschisis are the most common congenital ventral wall defects. Omphalocele is a midline defect characterized by eviscerated abdominal contents, which are covered by a protective sac. Omphalocele is associated with other anomalies in up to 90% of cases. Chromosomal abnormalities, including aneuploidies, occur in about 20% of cases.38,39 Beckwith-Wiedemann syndrome, CHARGE syndrome and VACTERL association are the most common genetic conditions associated with omphalocele (Table 12).57,25,36 In infants with omphalocele, careful examination for other anomalies, including cardiac, renal, and ophthalmologic, should be considered. In the absence of findings that point to a specific syndrome (i.e. Beckwith-Wiedemann syndrome), chromosomal microarray testing should be considered.

Table 12.

Ventral wall defects and associated conditions

Type of defect Genetic syndrome Associated features Potential evaluations Potential genetic studies
Omphalocele Beckwith-Wiedemann (See Table 1) (See Table 1) (See Table 1)
CHARGE (See Table 9) (See Table 9) (See Table 9)
Trisomy 13 (See Table 2) (See Table 2) (See Table 2)
Trisomy 18 (See Table 2) (See Table 2) (See Table 2)
VACTERL (See Table 11) (See Table 11) (See Table 11)
Gastroschisis None Cardiac anomalies
Intestinal atresia
Genitourinary anomalies
Musculoskeletal anomalies
Abdominal radiographs
Echocardiogram
Renal ultrasound
Skeletal radiographs
None

In contrast, the viscera in gastroschisis are not covered by a sac and protrude through a defect typically located just to the right of the umbilicus. Occasionally the sac covering an omphalocele can rupture, giving the appearance of gastroschisis, but the location of the ventral wall defect can be used to determine whether the most likely diagnosis is a ruptured omphalocele or gastroschisis. Gastroschisis is associated with young maternal age and maternal exposure to tobacco, alcohol and ibuprofen. Gastroschisis may be associated with intrauterine growth restriction and prematurity.40 Gastroschisis often occurs as an isolated defect but can have associated anomalies in up to one third of cases. The most common associated anomalies are intestinal atresias, although musculoskeletal, cardiac, urogenital and other gastrointestinal defects may be present.39 For infants who have apparently isolated gastroschisis or gastroschisis associated only with intestinal atresia, genetic testing is typically normal and recurrence risks are low.

POLYDACTYLY

Polydactyly is a common congenital anomaly and can occur on the ulnar (postaxial) or the radial (preaxial) aspects of the extremities. Of the two types, postaxial polydactyly is the most common. Postaxial polydactyly can manifest as a fully developed digit (Type A) or as a rudimentary cutaneous appendage (Type B). Type B polydactyly generally occurs as an isolated autosomal dominant condition with reduced penetrance. It is more common in African-American individuals with a prevalence of 1/143 live births versus 1/1339 in Caucasian infants. Type B polydactyly frequently occurs bilaterally. It is commonly treated in the nursery with suture ligation.4143

In contrast, preaxial polydactyly is less common, with a prevalence of up to 1 in 3000 live births but occurs more frequently in Caucasians. It also is associated with an increased incidence of systemic conditions like Fanconi anemia, chromosomal abnormalities, and VACTERL association (Table 13).36,37 Therefore, the finding of preaxial polydactyly should prompt a thorough evaluation for other congenital anomalies and consideration of genetic testing for Fanconi anemia (chromosomal breakage studies) at a minimum.41,42

Table 13.

Preaxial polydactyly and associated conditions

Differential diagnosis Associated features Potential evaluations Potential genetic studies
Fanconi anemia Microcephaly
Short stature
Pigmentary abnormalities
Thumb abnormalities (absent/hypoplastic, bifid, duplicated, etc)
Other upper extremity abnormalities
Lower extremity abnormalities
Genitourinary abnormalities
Pancytopenia
Hematologic studies including complete blood count and bone marrow aspirate
Renal ultrasound
Chromosomal breakage studies
Molecular testing; at least 16 genes, including FANCA and BRCA2
VACTERL association (See Table 11) (See Table 11) (See Table 11)

CONCLUSIONS

Neonatologists often have the unique opportunity to be the first to identify abnormalities in the neonate. Once a particular anomaly has been identified in a patient, a thorough examination with particular attention to other associated anomalies should be pursued, taking into consideration the patient's age, gender, race and family history. The tables summarize the anomalies discussed in this review, possible associated syndromes and findings, and suggested investigations. The ability to recognize anomalies and their associated conditions can be the key to the diagnosis and management of a patient and to appropriate recurrence risk counseling for the family.

KEY POINTS.

  • Congenital anomalies are a significant cause of neonatal intensive care unit (NICU) admissions

  • Congenital anomalies may be genetic in etiology or may be the result of teratogenic exposure or multifactorial inheritance (the interaction of both genetic and environmental factors)

  • The presence of a particular congenital anomaly may necessitate evaluation for the presence of other specific associated anomalies or genetic syndromes

  • Most genetic syndromes are defined by a specific pattern of congenital anomalies

  • Some congenital anomalies may be inherited within families as an isolated trait, highlighting the importance of taking a family history and of examining parents for similar anomalies, when appropriate

Best Practices Box.

What is the current practice?

Chromosomal microarray is the recommended first-line test for infants with dysmorphic features that are not specific to a well-recognized genetic syndrome.44 A genetics consultation should also be considered.

What changes in current practice are likely to improve outcomes?

Making a diagnosis in a child with dysmorphic features will enable providers to recognize occult malformations and provide surveillance for complications that may develop over time. It will also provide families information regarding the prognosis for their child and recurrence risks for future pregnancies.

Is there a Clinical Algorithm?

Major Recommendations

Whenever a dysmorphic feature is recognized, a comprehensive examination for the presence of other anomalies must be undertaken. If there are other features of a well-delineated syndrome present, further evaluation including a detailed family history, diagnostic studies and genetic testing should be pursued (please refer back to the tables for examples and further information).

If features of a well-delineated syndrome are not recognized but there are at least 3 minor anomalies present, further evaluation including a detailed family history and a chromosomal microarray should be obtained. Also, the patient should be evaluated for the presence of an occult major malformation, as the presence of 3 or more minor anomalies is associated with a significantly increased risk of the occurrence of an occult major malformation.2

Clinical Algorithm(s)

(Please see above)

Rating for the Strength of the Evidence

Chromosomal microarray is the first-line test for infants with dysmorphic features that are not specific to a well-recognized genetic syndrome per the ACMG guidelines.44 This test has a diagnostic yield of 15-20%.8

Bibliographic Source(s)

Adam M, Hudgins L. The importance of minor anomalies in the evaluation of the newborn. Neoreviews. 2003;4:e99–104.

Manning M, Hudgins L. Array-based technology and recommendations for utilization in the medical genetics practice for detection of chromosomal abnormalities. Genet Med 2010; 12:742–745.

Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2010; 86:749–64.

Summary Statement

Whenever a dysmorphic feature is recognized, a comprehensive evaluation for the presence of other dysmorphic features and a possible underlying genetic syndrome must be undertaken to help guide management and provide appropriate counseling to the family.

REFERENCES

  • 1.Synnes AR, Berry M, Jones H, et al. Infants with congenital anomalies admitted to neonatal intensive care units. Am J Perinatol. 2004;21:199–207. doi: 10.1055/s-2004-828604. [DOI] [PubMed] [Google Scholar]
  • 2.Adam M, Hudgins L. The importance of minor anomalies in the evaluation of the newborn. Neoreviews. 2003;4:e99–104. [Google Scholar]
  • 3.Hay WW. Care of the infant of the diabetic mother. Curr Diab Rep. 2012;12:4–15. doi: 10.1007/s11892-011-0243-6. [DOI] [PubMed] [Google Scholar]
  • 4.Adam M, Hudgins L, Carey J, et al. Preaxial hallucal polydactyly as a marker for diabetic embryopathy. Birth Defects Res A Clin Mol Teratol. 2009;85:13–9. doi: 10.1002/bdra.20503. [DOI] [PubMed] [Google Scholar]
  • 5.Pettenati M, Haines J, Higgins R, et al. Wiedemann-Beckwith syndrome: presentation of clinical and cytogenetic data on 22 new cases and review of the literature. Hum Genet. 1986;74:143–54. doi: 10.1007/BF00282078. [DOI] [PubMed] [Google Scholar]
  • 6.Weksberg R, Shuman C, Smith AC. Beckwith-Wiedemann syndrome. Am J Med Genet C Semin Med Genet. 2005;137C:12–23. doi: 10.1002/ajmg.c.30058. [DOI] [PubMed] [Google Scholar]
  • 7.Carey J. Trisomy 18 and 13 syndromes. In: Cassidy S, Allanson J, editors. Management of genetic syndromes. 3rd ed. John Wiley & Sons; New York: 2010. pp. 807–23. [Google Scholar]
  • 8.Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2010;86:749–64. doi: 10.1016/j.ajhg.2010.04.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.American College of Obstetricians and Gynecologists ACOG Practice bulletin no. 134: fetal growth restriction. Obstet Gynecol. 2013;121:1122–33. doi: 10.1097/01.AOG.0000429658.85846.f9. [DOI] [PubMed] [Google Scholar]
  • 10.Shih EM, Graham JM. Review of genetic and environmental factors leading to hypospadias. Eur J Med Genet. 2014 doi: 10.1016/j.ejmg.2014.03.003. [Epub ahead of print] [DOI] [PubMed] [Google Scholar]
  • 11.Tollefson MM. Aplasia cutis congenita. Neoreviews. 2012;13:e285–e292. [Google Scholar]
  • 12.Yoshihara A, Noh J, Yamaguchi T, et al. Treatment of graves’ disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation. J Clin Endocrinol Metab. 2012;97:2396–403. doi: 10.1210/jc.2011-2860. [DOI] [PubMed] [Google Scholar]
  • 13.Cohen I, Silberstein E, Perez Y, et al. Autosomal recessive Adams-Oliver syndrome caused by homozygous mutation in EOGT, encoding an EGF domain-specific O-GlcNAc transferase. Eur J Hum Genet. 2014;22:374–8. doi: 10.1038/ejhg.2013.159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Olsen CL, Hughes JP, Youngblood LG, Sharpe-Stimac M. Epidemiology of holoprosencephaly and phenotypic characteristics of affected children: New York State, 1984-1989. Am J Med Genet. 1997;73:217–26. doi: 10.1002/(sici)1096-8628(19971212)73:2<217::aid-ajmg20>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  • 15.Gropman AL, Muenke M. Holoprosencephaly. In: Cassidy S, Allanson J, editors. Management of genetic syndromes. 3rd ed. John Wiley & Sons; New York: 2010. pp. 441–60. [Google Scholar]
  • 16.Nanni L, Ming JE, Bocian M, et al. The mutational spectrum of the sonic hedgehog gene in holoprosencephaly: SHH mutations cause a significant proportion of autosomal dominant holoprosencephaly. Hum Mol Genet. 1999;8:2479–88. doi: 10.1093/hmg/8.13.2479. [DOI] [PubMed] [Google Scholar]
  • 17.Shapira M, Borochowitz ZU. Asymmetric crying facies. Neoreviews. 2009;10:e502–e509. [Google Scholar]
  • 18.Cancrini C, Puliafito P, Digilio MC, et al. Clinical features and follow-up in patients with 22q11.2 deletion syndrome. J Pediatr. 2014;164:1475–80. doi: 10.1016/j.jpeds.2014.01.056. [DOI] [PubMed] [Google Scholar]
  • 19.Heike CL, Hing A V, Aspinall CA, et al. Clinical care in craniofacial microsomia: a review of current management recommendations and opportunities to advance research. Am J Med Genet C Semin Med Genet. 2013;163C:271–82. doi: 10.1002/ajmg.c.31373. [DOI] [PubMed] [Google Scholar]
  • 20.Kugelman A, Tubi A, Bader D, et al. Pre-auricular tags and pits in the newborn. J Pediatr. 2002;141:388–91. doi: 10.1067/mpd.2002.126600. [DOI] [PubMed] [Google Scholar]
  • 21.Wang RY, Earl DL, Ruder RO, et al. Syndromic ear anomalies and renal ultrasounds. Pediatrics. 2001;108:e32–e32. doi: 10.1542/peds.108.2.e32. [DOI] [PubMed] [Google Scholar]
  • 22.Setó-Salvia N, Stanier P. Genetics of cleft lip and/or cleft palate: association with other common anomalies. Eur J Med Genet. 2014 doi: 10.1016/j.ejmg.2014.04.003. [Epub ahead of print] [DOI] [PubMed] [Google Scholar]
  • 23.Battaile KP, Steiner RD. Smith-Lemli-Opitz syndrome: the first malformation syndrome associated with defective cholesterol synthesis. Mol Genet Metab. 2000;71:154–62. doi: 10.1006/mgme.2000.3020. [DOI] [PubMed] [Google Scholar]
  • 24.Dixon MJ, Marazita ML, Beaty TH, et al. Cleft lip and palate: understanding genetic and environmental influences. Nat Rev Genet. 2011;12:167–78. doi: 10.1038/nrg2933. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Bergman JEH, Janssen N, Hoefsloot LH, et al. CHD7 mutations and CHARGE syndrome: the clinical implications of an expanding phenotype. J Med Genet. 2011;48:334–42. doi: 10.1136/jmg.2010.087106. [DOI] [PubMed] [Google Scholar]
  • 26.Robin N, Moran R, Warman M, et al. Pagon R, Adam M, Ardinger H, Bird T, Dolan C, Fong C-T, et al., editors. Stickler syndrome. GeneReviews. 2011 [Google Scholar]
  • 27.Tighe D, Petrick L, Cobourne MT, et al. Cleft Lip and Palate: Effects on Neonatal Care. Neoreviews. 2011;12:e315–e324. [Google Scholar]
  • 28.Jenkins KJ, Correa A, Feinstein JA, et al. Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation. 2007;115:2995–3014. doi: 10.1161/CIRCULATIONAHA.106.183216. [DOI] [PubMed] [Google Scholar]
  • 29.Beck A, Hudgins L. Congenital cardiac malformations in the neonate: isolated or syndromic. Neoreviews. 2003;4:e105–e110. [Google Scholar]
  • 30.Sybert VP, McCauley E. Turner’s syndrome. N Engl J Med. 2004;351:1227–38. doi: 10.1056/NEJMra030360. [DOI] [PubMed] [Google Scholar]
  • 31.Bull MJ. Committee on Genetics. Health supervision for children with Down syndrome. Pediatrics. 2011;128:393–406. doi: 10.1542/peds.2011-1605. [DOI] [PubMed] [Google Scholar]
  • 32.Pierpont ME, Basson CT, Benson DW, et al. Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation. 2007;115:3015–38. doi: 10.1161/CIRCULATIONAHA.106.183056. [DOI] [PubMed] [Google Scholar]
  • 33.Roberts AE, Allanson JE, Tartaglia M, et al. Noonan syndrome. Lancet. 2013;381:333–42. doi: 10.1016/S0140-6736(12)61023-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.De Jong EM, Felix JF, Deurloo JA, et al. Non-VACTERL-type anomalies are frequent in patients with esophageal atresia/tracheo-esophageal fistula and full or partial VACTERL association. Birth Defects Res A Clin Mol Teratol. 2008;82:92–7. doi: 10.1002/bdra.20437. [DOI] [PubMed] [Google Scholar]
  • 35.Brosens E, Ploeg M, van Bever Y, et al. Clinical and etiological heterogeneity in patients with tracheo-esophageal malformations and associated anomalies. Eur J Med Genet. 2014 doi: 10.1016/j.ejmg.2014.05.009. [Epub ahead of print] [DOI] [PubMed] [Google Scholar]
  • 36.Solomon BD, Baker LA, Bear KA, et al. An approach to the identification of anomalies and etiologies in neonates with identified or suspected VACTERL (vertebral defects, anal atresia, tracheo-esophageal fistula with esophageal atresia, cardiac anomalies, renal anomalies, and limb anomalies). J Pediatr. 2014;164:451–7. doi: 10.1016/j.jpeds.2013.10.086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Khincha PP, Savage SA. Genomic characterization of the inherited bone marrow failure syndromes. Semin Hematol. 2013;50:333–47. doi: 10.1053/j.seminhematol.2013.09.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Agopian A, Marengo L, Mitchell LE. Descriptive epidemiology of nonsyndromic omphalocele in Texas, 1999-2004. Am J Med Genet A. 2009;149A:2129–33. doi: 10.1002/ajmg.a.33000. [DOI] [PubMed] [Google Scholar]
  • 39.Benjamin B, Wilson GN. Anomalies associated with gastroschisis and omphalocele: analysis of 2825 cases from the Texas Birth Defects Registry. J Pediatr Surg. 2014;49:514–9. doi: 10.1016/j.jpedsurg.2013.11.052. [DOI] [PubMed] [Google Scholar]
  • 40.Mac Bird T, Robbins JM, Druschel C, et al. Demographic and environmental risk factors for gastroschisis and omphalocele in the National Birth Defects Prevention Study. J Pediatr Surg. 2009;44:1546–51. doi: 10.1016/j.jpedsurg.2008.10.109. [DOI] [PubMed] [Google Scholar]
  • 41.Guo B, Lee S, Pakisma N. Polydactyly: a review. Bull Hosp Joint Dis. 2013;71:17–23. [PubMed] [Google Scholar]
  • 42.Castilla E, Paz J, Mutchinick O, et al. Polydactyly: a genetic study in South America. Am J Hum Genet. 1973;25:405–12. [PMC free article] [PubMed] [Google Scholar]
  • 43.Singer G, Thein S, Kraus T, et al. Ulnar polydactyly - an analysis of appearance and postoperative outcome. J Pediatr Surg. 2014;49:474–6. doi: 10.1016/j.jpedsurg.2013.06.029. [DOI] [PubMed] [Google Scholar]
  • 44.Manning M, Hudgins L. Array-based technology and recommendations for utilization in the medical genetics practice for detection of chromosomal abnormalities. Genet Med. 2010;12:742–745. doi: 10.1097/GIM.0b013e3181f8baad. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES